Search
Search Results
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
2468PDF: 2977Supplementary: 357Appendix: 293 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2863PDF: 708Conflict of interest: 336SUPPLEMENTARY MATERIAL: 283HTML: 83 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
867PDF: 232Supplementary: 168Appendix: 121HTML: 53 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
889PDF: 272Supplementary: 161Appendix: 122HTML: 76 -
Modulation of cardiac metabolism in heart failure
2461PDF: 1202HTML: 60 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2507PDF: 426Appendix B: 467Appendix A: 332HTML: 6 -
The impact of frailty on in-hospital outcomes in patients with HFrEF
367PDF: 138Supplementary: 35HTML: 16 -
Evolving targets for heart failure: the journey so far
2159pdf: 383HTML: 4 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1298pdf: 294Supplementary Material: 49HTML: 158 -
-
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
2126PDF: 576SUPPLEMENTARY MATERIAL: 321GRAPHICAL ABSTRACT: 281HTML: 44 -
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1234PDF: 318Supplementary: 171HTML: 142

